- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 112.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 111.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.85M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$27.22M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$33.85M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $160.02M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $44.91M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $108.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.38B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.42B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $252.43M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $375.58M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $919.57M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.06B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $216.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $408.18M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.61B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.75B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.98 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.98 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.30 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $81.74M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $21.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$219.85M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$133.89M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$370.37M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$147.65M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $25.55M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $18.66M |
| Revenue | Q1 2026 · Mar 31, 2026 | $71.02M |
| Revenue | Q1 2026 · Mar 31, 2025 | $21.82M |